✦ LIBER ✦

Antitumor and therapeutic effects of spleen cells from tumor-bearing mice cultured with T cell growth factor and soluble tumor extract

✍ Scribed by Norimichi Kan; Kazuhisa Ohgaki; Takashi Inamoto; Hiroshi Kodama

Publisher: Springer-Verlag
Year: 1984
Tongue: English
Weight: 872 KB
Volume: 18
Category: Article
ISSN: 0340-7004
DOI: 10.1007/bf00205514

No coin nor oath required. For personal study only.

✦ Synopsis

Spleen cells of BALB/c mice that had been inoculated with syngeneic plasmacytoma MOPC 104E were cultured for 11 days in T-cell growth factor (TCGF) and ultrasonicated tumor extract (USE). Cultured lymphocytes (MOPC-CL) possessed three-fold more lytic units than normal spleen cells cultured in TCGF without USE (N-CL). Moreover, the in vivo neutralization assay suggested that MOPC-CL were composed of at least two populations, one possessing tumor-specific and the other nonspecific antitumor activity. When 2 X 10(7) of MOPC-CL were administered IP to mice that had been inoculated IP with 10(5) MOPC 104E cells 5 days previously marginal prolongation of survival was observed. This effect was not augmented by the single injection of a larger number (5 X 10(7] of CL, but was augmented by the repeated daily administration for 4 days (from day 5 to day 8 after the inoculation) of the same total number (5 X 10(7] of CL. In addition, IP injection of the streptococcal preparation OK432 before the transfer of CL significantly enhanced the therapeutic efficacy, and resulted in a cure rate of 20%. The mechanism of this combined effect appears to involve the effect of OK432 on interleukin 2 (IL-2) regulation systems in vivo. Our culture system with TCGF and USE and our therapy system with OK432 and CL allow the clinical application of adoptive immunotherapy for the many types of solid cancers.

📜 SIMILAR VOLUMES

An immunoregulatory factor associated wi

An immunoregulatory factor associated with spleen cells from tumor-bearing animals. I. Effect on tumor growth and antibody production

✍ Noah Isakov; Shraga Segal; Nurit Hollander; Michael Feldman 📂 Article 📅 1978 🏛 John Wiley and Sons 🌐 French ⚖ 548 KB

## Abstract An immunopotentiating factor associated with spleen cells of C57BL/6J mice bearing the 3LL tumor is described. Supernatants of cultured spleen cells from tumor‐bearing mice (TBM) augmented the generation of both 19S and 7S antibody‐producing cells, when injected with sheep erythrocytes

Evolution of cell-mediated antitumor imm

Evolution of cell-mediated antitumor immunity in mice bearing a syngeneic chemically induced tumor. Influence of tumor growth, surgical removal and treatment with irradiated tumor cells

✍ Jean Belehradek Jr.; Georges Barski; Monique Thonier 📂 Article 📅 1972 🏛 John Wiley and Sons 🌐 French ⚖ 732 KB

## Abstract The evolution of the specific cell‐mediated immune status was studied in C57BL/6 mice bearing a chemically induced syngeneic sarcoma, the TBL CL2 tumor. Peritoneal cells (PC) as the source of immunocompetent cells were repeatedly harvested from the same groups of mice checked in the in

Evaluation of recombinant human tumor ne

Evaluation of recombinant human tumor necrosis factor by cell electrophoresis. II. In vivo effect of recombinant human tumor necrosis factor on cell populations and natural killer-activity in spleen of tumor-bearing mice

✍ Dr. Joachim Rychly; Eberhard Knippel; Jürgen Milleck; Wolfgang Schütt; Horst Niz 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 533 KB

Specific cytostatic effect of lymph node

Specific cytostatic effect of lymph node cells from normal and T cell-deficient mice on syngeneic tumor target cells in vitro and its specific abrogation by body fluids from syngeneic tumor-bearing mice

✍ Eunice Chia; H. Festenstein 📂 Article 📅 1973 🏛 John Wiley and Sons 🌐 English ⚖ 427 KB 👁 1 views

Some approaches to improve the therapeut

Some approaches to improve the therapeutic effectiveness of adoptive chemoimmunotherapy with spleen cells from melphalan-treated BALB/C mice bearing a large MOPC-315 tumor

✍ Larry M. Weiskirch; Margalit B. Mokyr 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 French ⚖ 1020 KB

## Abstract Spleen cells from BALB/c mice that are in the process of eradicating a large MOPC‐315 tumor following low‐dose L‐PAM therapy (L‐PAM TuB spleen cells) were previously shown to be capable of bringing about the complete regression of a large (15 to 20 mm) s.c. MOPC‐315 tumor in a substanti

Therapeutic effects of monoclonal antibo

Therapeutic effects of monoclonal antibody g250, interferons and tumor necrosis factor, in mice with renal-cell carcinoma xenografts

✍ J. van Dijk; H. Uemura; A. J. M. C. Beniers; W. P. Peelen; S. Th. Zegveld; G. J. 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 French ⚖ 1015 KB

Because renal-cell carcinoma (RCC) is considered relatively resistant to radio-and chemotherapy, RCC patients may benefit from new treatment modalities, e.g. immunotherapy. In vitro and in vivo studies suggest that combinations of cytokines such as interferon y or interferon a (IFN-y, IFN-a) and tum